10,000 Hours of Play by OP Hero: Tu Youyou

In 1969, a 39-year-old pharmacologist with no doctorate, no foreign training, and no membership in any Chinese academy was handed a problem that had already broken several teams of better-credentialed scientists. The problem was malaria. Soldiers fighting in Vietnam jungles were dying of it faster than they were dying of bullets. The Chinese government had launched a classified national program called Project 523 to find a cure inside traditional Chinese medicine. After three years of screening, the program had nothing.

The pharmacologist’s name was Tu Youyou. Six years later, she would have isolated a compound that has gone on to save several million lives. Forty-six years after that, she would walk to a podium in Stockholm and become the first mainland-China-trained scientist to win a Nobel Prize in a science category. She had no PhD when she did the work. She still did not when she won the prize.

Most accounts of Tu Youyou stop at the headline (“Nobel laureate discovered artemisinin”). The interesting question is not what she found. The interesting question is structural: how did the same operator, working inside one of the most resource-starved scientific environments of the 20th century, beat better-funded teams to a treatment for one of humanity’s oldest killers, and then keep going for another forty years? The 10,000 Hours of Play framework gives a usable answer.

About Yu-kai Chou

Yu-kai Chou is the author of 10,000 Hours of Play — the book that treats your life as the most important game you’ll ever build a character in, and gives you the 6-Step framework (Game · Attributes · Role · Skills · Allies · Quests) to play it on purpose. He has spent two decades developing the system through which this post analyzes its OP Hero, and applies it to his own life and to the lives of the people he advises around the world.

Chou’s other framework, the Octalysis Framework, has been applied by LEGO, Microsoft, Porsche, Coca-Cola, Salesforce, and MrBeast, impacting over 1.5 Billion Users. He has taught the methodology at Harvard, Stanford, Yale, Tesla, Google, BCG, and IDEO, and has advised governments in eight nations including Ukraine, the United Kingdom, the Kingdom of Bahrain, Singapore, Taiwan, the Netherlands, Kazakhstan, and South Korea.

His work has been cited by Harvard, Stanford, MIT, Forbes, Wall Street Journal, Wired, US Department of Energy, NIST, NSF, NCBI, US Department of Education, ClinicalTrials.gov, and Google Scholar — with 3,700+ more academic publications. Explore his books here.

What I find instructive about Tu Youyou’s build is how much of the breakthrough is sitting inside a single Attribute most people would write off: comfort with reading across knowledge systems that nominally don’t speak to each other. Her advantage was not better lab equipment than her competitors. It was that she had been trained to take Ge Hong’s 4th-century instruction and a 1960s organic-chemistry textbook seriously at the same time. The lesson I would lift for your own run is at Step 2: the rarest Attribute you have is often the one your formal credentials don’t reward, and the move that compounds is finding a Game where the under-rewarded Attribute is the load-bearing one.

Step 1: The Game — What Tu Youyou Was Actually Playing

One sentence: pull potent therapies for human-killing parasitic and infectious diseases out of traditional Chinese materia medica, and validate them with modern science.

That sentence covers her arrival at the Institute of Chinese Materia Medica at the China Academy of Traditional Chinese Medicine in 1955. It covers the two years she spent in the Chinese countryside from 1959 to 1961 studying local remedies for tuberculosis and schistosomiasis. It covers her appointment in January 1969 as the head of the Institute’s antimalarial research group inside the classified Project 523. It covers the 1971 ether-extraction breakthrough on Sample 191. It covers her decades of follow-on work into the 2010s on artemisinin resistance and dihydroartemisinin-piperaquine combination therapies. And it covers her 2011 Nature Medicine paper on the discovery of artemisinin, framed as a gift from traditional Chinese medicine to the world — the title is itself a one-sentence Game statement.

The substrate kept moving underneath her. Tuberculosis became schistosomiasis became malaria became drug resistance. The Game did not. The Project 523 ethos that the press would later call her Three-No orientation, beyond the no-PhD, no-academy, no-overseas-training reading, has often been described as a vow-like commitment to push through hardship, accept personal risk, and refuse credit-seeking as a motivator. Read inside the 6-Step life-as-game frame, that orientation is not a humility line. It is the part of the one-sentence mission that protects the Game from being deformed by the other two things that usually deform careers: comfort and credit.

This matters because the Game an operator picks is what determines which Attributes are load-bearing and which are decorative. Most pharmacology careers in 1955 China assigned the highest weight to credentials, lab access, and Western training. Tu Youyou’s Game inverted that ranking. The load-bearing Attribute became cross-system reading, not pedigree, and she had it in abundance.

Step 2: Attributes — The Innate Stats

Five Attributes show up early in the biographical record and stay online for the full forty-year run.

Cross-system pattern recognition. Tu Youyou was admitted to Beijing Medical College in 1951, where she studied pharmacy with a curriculum that deliberately combined modern Western pharmacology with traditional Chinese materia medica. By her own later accounting she read pharmacology and organic-chemistry textbooks “line by line” while also working through classical TCM texts. The Attribute is the willingness to hold two epistemologies in the head at the same time without forcing them to argue. It is the same Attribute the Talent Triangle Method would mark as the multiplier on her career: every Skill downstream of cross-system reading is worth more because of it.

Methodical, detail-obsessed curiosity. Colleagues consistently describe her early career as defined by an unusual willingness to log extraction conditions, solvent variations, and small physical changes in extracts that other researchers ignored. The 1971 breakthrough came not from a flash of insight but from her noticing that high-temperature decoction — the default TCM preparation — kept destroying activity, and then testing solvent and temperature systematically until ether at low temperature worked. That kind of careful logging is not a habit she picked up in 1969. The biographies trace it back to her undergraduate years.

High risk tolerance for personal cost. In 1972, with toxicity of the early refined artemisinin extract still uncertain and animal data incomplete, Tu and two of her colleagues volunteered as the first human subjects for the compound. She would later describe this as a “team encouragement” decision. It is also an Attribute. Most operators given the same data would have asked for another round of animal studies. She was already willing to absorb the risk to keep the project moving.

Tenacity under bad conditions. Project 523 was a Cultural Revolution-era operation. The political environment was hostile to scientists, lab resources were scarce, and during the early years of the project she was separated from her young daughters, who had to be raised partly by relatives and a nursery. The malaria research itself ran on roughly four years (1969–1972) of repeated screening failures across more than two thousand traditional prescriptions before the ether-extraction breakthrough. Colleagues uniformly describe her in those years with the Chinese term 坚韧 (unyielding). The Attribute predates the project; the project tested whether it would survive.

Low ego under collective attribution. Project 523 was classified, and for years many of Tu’s specific contributions were either collectively attributed to the program or published anonymously. She did not hold a professorship. She did not hold a doctorate. She remained largely unknown outside China until the 2011 Lasker-DeBakey Clinical Medical Research Award. When asked in interviews whether the lack of credit had bothered her, her recurring reply was that the achievement was saving lives, not personal honor. That kind of consistent low-ego orientation reads in the biographies as innate rather than performed.

Step 3: Role(s) — The Character Class Across Chapters

Four Roles, each one feeding into the next.

From 1951 to 1959 she was the Hybrid Apprentice. She studied at Beijing Medical College’s School of Pharmacy from 1951 to 1955, took her degree, and joined the Institute of Chinese Materia Medica in Beijing in 1955. From 1959 to 1962 she also completed a special two-and-a-half-year course in classical Chinese medicine sponsored by the Ministry of Health, which formalized her dual training. The Role focus was building Western pharmacology and TCM fluency in one head.

From 1959 to 1965 she was the Field Ethnopharmacologist. She spent roughly two years in the Chinese countryside investigating local remedies for tuberculosis and schistosomiasis. The Role was boots-on-the-ground: collecting plant samples, watching how local practitioners actually prepared remedies, and logging the gap between what the classical texts said and what worked in practice. The same Attribute stack that would later beat Project 523 was being calibrated here, on the cheaper problem of parasitic infections nobody was racing to cure.

From 1969 to 1978 she was the Classified-Project Lead Scientist. On January 21, 1969 the People’s Liberation Army’s Project 523 leadership assigned her to lead a small group at the Institute of Chinese Materia Medica focused on antimalarial herbs. The Role was: design the screening method, supervise the extraction work, coordinate animal testing, and shepherd compounds into human trials. The 1971 ether-extraction breakthrough on Sample 191 (qinghao, Artemisia annua) happened inside this Role. So did the 1972 self-experimentation and the first clinical trials of artemisinin extract in Hainan and Yunnan. The chapter shows up in similar shape inside Katherine Johnson’s run at NASA: an under-credentialed operator quietly anchors a national-stakes project from inside a hostile credentialing system, while the official credit clusters around other names.

From 1979 onward she has been the Drug Optimization Strategist. The Institute of Chinese Materia Medica filed and published on the chemical structure of artemisinin in 1977 (initial publication was anonymous due to the classified nature of the program). Through the 1980s and 1990s she led work on dihydroartemisinin and combination therapies that became the World Health Organization standard for uncomplicated Plasmodium falciparum malaria. The Role is the long tail of the original Game: not “what can I find” but “how do we keep this working as the parasite evolves.” She was still publishing on artemisinin resistance into her eighties.

Step 4: Skills — The Real-Life Game Skills Tu Youyou Mastered

Five canon Real-Life Game Skills carry the build. Each one earns its slot from a specific moment in the public record.

Ley Line Infusion (Mage). Quickly absorbing a large amount of knowledge in a subject. The clearest firing is the 1969–1971 literature campaign. Tu’s team screened roughly 2,000 traditional Chinese prescriptions and reviewed more than 640 classical materia medica texts, narrowing the field to around 200 plant candidates with documented antimalarial use. No team on Project 523 had absorbed the TCM corpus that thoroughly. Three years of compressed reading became the dataset everything that followed was searching inside. Most operators reach for new experiments when stuck; she reached deeper into existing knowledge first.

Cognitive Lens (Mage). Zooming in on details and zooming out for strategy. The famous case is the 4th-century text Zhouhou Beiji Fang by Ge Hong, which she read closely during the deadlocked early 1971 work. The recipe for treating intermittent fever (which we now read as malaria) reads, in Tu Youyou’s own translation in her 2011 Nature Medicine commentary: “A handful of qinghao immersed with 2 liters of water, wring out the juice and drink it all.” The micro-detail nobody else had weighted is “soak” and “wring out the juice” rather than “decoct” or “boil.” She zoomed in to that single instruction, zoomed out to her chemistry training, and inferred that boiling was destroying the active compound. The next experiment used low-temperature ether extraction. Sample 191 worked. The same Skill family anchors the canonical Mage-and-Warlock-pattern entries in the 10K HP catalog.

Lich Grind (Warlock). Intense, secluded work periods. The 1969–1972 stretch is the canonical Lich Grind in modern science. Four years of repeated screening failures against the most lethal form of malaria, under classified-project secrecy, in a country whose political environment was actively dangerous for the scientific class. She and her team ran extractions, animal infections, dose-response work, and toxicity checks at a pace and isolation level that most laboratories would consider unsustainable past one year. The Skill is not the breakthrough month in 1971. The Skill is the three years of failure that made the breakthrough month possible.

Undying Rage (Warrior). Activating survival instincts to defeat an overwhelming challenge. The clearest firing is the July 1972 decision to self-experiment. The refined artemisinin extract had cleared animal trials but the team could not be certain it was safe for humans. Tu and two colleagues admitted themselves to a Beijing hospital and took the extract themselves before any external clinical trial. She would later write, in her 2011 Nature Medicine commentary: “During the Cultural Revolution, there were no practical ways to perform clinical trials of new drugs. So, in order to help patients with malaria, my colleagues and I bravely volunteered to be the first people to take the extract.” Undying Rage in the canon is not bravery; it is the move where you make the cost of stopping higher than the cost of pushing through. The self-experiment did exactly that. After it, the program could not credibly delay.

Mastermind (Ranger). Creating, adapting and executing complex multi-step plans. Project 523 under her group’s coordination is the case study. Step one was the 640-text literature pass. Step two was the 200-candidate plant shortlist. Step three was the extraction methodology pivot to low-temperature solvents. Step four was the animal-model validation on rodent malaria, then primate malaria. Step five was the self-experiment to unlock human trials. Step six was the field clinical trials in Hainan and Yunnan in 1972 and 1973. Step seven was the structural elucidation of artemisinin in 1975 and the eventual 1977 publication. Each individual step was a normal research move; the chain of them is what Mastermind looks like when it is doing its job. Another version of the same Skill shows up inside Jane Goodall’s primate-research arc, where a single under-credentialed woman quietly executed a multi-decade research plan from inside a field that had not been built to accommodate her.

Step 5: Allies — The People Who Multiplied Tu Youyou

Lou Zhiyun and the Institute team. Lou Zhiyun was one of Tu’s earliest collaborators on the qinghao extraction work and is credited alongside her on several of the foundational extraction-method papers from the mid-1970s. The Institute of Chinese Materia Medica group at Dongzhimen in Beijing was the load-bearing team. Without them, the 2,000-prescription screen and the 191 ether-extraction work do not run. The Nobel went to one name; the work was done by a party.

Ge Hong. The 4th-century alchemist and physician whose Zhouhou Beiji Fang (“Emergency Prescriptions Kept Up One’s Sleeve”) carried the cold-soak preparation note that broke the 1971 deadlock. Ge Hong is the rarest kind of Ally: a time-displaced mentor, dead for sixteen hundred years, whose work was still load-bearing because Tu Youyou had built the cross-system reading muscle to actually use it. Most modern pharmacologists would have read the same passage and dismissed it. She did not.

Project 523 leadership and the People’s Liberation Army. The classified national program supplied the political cover, the funding, and the cross-institutional coordination across more than sixty Chinese research units that allowed a Cultural Revolution-era research push to happen at all. The Ally relationship here is unusual: the program was strict, often punitive, and the credit-allocation rules were collectivist enough that Tu’s individual contribution was obscured for decades. But without Project 523’s coordination layer the qinghao thread does not get sequenced, screened, and clinically tested at all.

The rodent-malaria team at the Academy of Military Medical Sciences. Specialists at the Institute of Microbiology and Epidemiology who ran the animal models that validated artemisinin’s activity before the human trials. The model-malaria team is the unsung Ally on every major antimalarial breakthrough in the 20th century, and Project 523 was no exception.

Her family. Tu’s husband Li Tingzhao, a metallurgical engineer, supported the work through years in which she was separated from her two daughters by both project secrecy and physical relocation. The cost of that period was real and lifelong, and the relationship survived it. The home-and-mission continuity that lets a forty-year research career run is often the least-discussed Ally infrastructure, and in her case it was non-trivial.

Step 6: Quests — The Milestones That Shaped the Saga

December 30, 1930 — Born in Ningbo, Zhejiang Province. Survives a tuberculosis infection at age 16 that pulls her toward medicine as a career.

1951 — Admitted to Beijing Medical College, School of Pharmacy. Enters the program that combines Western pharmacology with classical Chinese materia medica.

1955 — Joins the Institute of Chinese Materia Medica. Beijing. The base she will work from for the rest of her career.

1959–1962 — Special course in classical Chinese medicine. Two-and-a-half-year Ministry of Health course that formalizes her dual training. The cross-system Attribute hardens into a credential.

1959–1961 — Field study in the countryside. Investigates TCM remedies for tuberculosis and schistosomiasis. The Field Ethnopharmacologist Role goes live.

January 21, 1969 — Appointed head of the Institute’s antimalarial group inside Project 523. The classified national program is already three years old and has produced no candidate. She inherits the deadlock.

1969–1971 — The 640-text, 2,000-prescription literature campaign. Ley Line Infusion fires for two years before any laboratory result.

Early 1971 — The Ge Hong inference. Re-reading Zhouhou Beiji Fang, she notices the cold-soak preparation note and infers that high-temperature extraction is destroying the active compound.

October 4, 1971 — Sample 191. Low-temperature ether extraction of Artemisia annua achieves 100 percent inhibition of Plasmodium in the rodent model. The four-year deadlock is over.

July 1972 — Self-experimentation. Tu and two colleagues take the refined extract themselves at a Beijing hospital. No adverse effects. Clinical trials follow.

August–October 1972 — First field clinical trials in Hainan. More than 20 patients treated. The drug works. The setback in this Quest is not in the lab; it is in the international scientific community’s slow recognition, which will take another four decades.

1975 — Structural elucidation of artemisinin. The sesquiterpene lactone structure with the rare endoperoxide bridge is confirmed. The 1977 publication appears under the collective name “Qinghaosu Antimalaria Coordinating Research Group” — anonymous in the way Cultural Revolution-era science required.

September 2011 — Lasker-DeBakey Clinical Medical Research Award. The work breaks out of China for the first time. Tu is 80 years old.

October 5, 2015 — Nobel Prize in Physiology or Medicine. Shared with William C. Campbell and Satoshi Ōmura. First China-trained scientist to win a Nobel in a science category for work done in mainland China. She is 84.

2017 onward — National honors and continued work on resistance. Awarded China’s State Preeminent Science and Technology Award in 2017. Continues publishing on artemisinin combination therapies and emerging resistance into her late eighties.

What You Can Steal From Tu Youyou’s Build

Three transferable patterns.

First, the most valuable Attribute you have is usually the one your formal training does not reward. Cross-system reading was not on any 1965 Chinese pharmacology evaluation form. It was not what got you tenure or an academy seat. It also turned out to be the only Attribute capable of cracking a problem that better-credentialed teams had failed to crack for three years. Audit your own stack: which Attribute is yours that the official rubric in your field treats as a hobby? That is likely the one your Game should be built around.

Second, when stuck, read deeper into existing knowledge before reaching for new experiments. The 1971 breakthrough did not come from new chemistry. It came from a 4th-century instruction the modern field had skimmed past. Most operators in a research deadlock reach for new tools, new collaborators, new funding. Tu Youyou reached for older texts, read them carefully, and found that the deadlock was an interpretation failure, not a knowledge failure. The next time your work is stuck, try the Ley Line Infusion (Mage) move first. It is cheaper, faster, and more often right than the field will tell you.

Third, the Game is allowed to outlive the credit. The Nobel arrived forty-six years after the work started, and for most of those decades Tu’s specific contributions were collectively attributed or anonymous. If she had built her career around credit, the four-year Lich Grind and the 1972 self-experiment would not have been worth the price. She built her career around the Game itself, and the credit caught up when it was ready. If your one-sentence mission needs external recognition to keep firing, it is not your Game yet. It is your reward function. The fuller library of builds where the operator stayed on the Game and let the credit lag lives in the OP Hero profiles hub, and Tu Youyou’s run is one of the cleanest examples of why it matters.

Where this framework comes from

Related Reading

• All OP Hero Profiles — the full catalog of builds analyzed through the 6 Steps.
• Katherine Johnson — OP Hero profile — the closest sibling for an under-credentialed woman scientist quietly anchoring a national-stakes program from inside a hostile credentialing system.
• Hedy Lamarr — OP Hero profile — another woman inventor whose work was unrecognized for decades while it silently powered a field she got no credit for.
• Jane Goodall — OP Hero profile — the Mastermind (Ranger) parallel: a researcher without the standard credentials running a multi-decade plan from inside a field that had not been built to accommodate her.
• The Talent Triangle Method — how to pick the Attribute, Skill and Role combinations your own Game is built on.
• The Skills Spectrum — Specialist, Dabbler, Master, Strategy. The taxonomy under every Skill mention in this profile.

WOULD YOU LIKE YU-KAI CHOU TO WORK WITH YOUR ORGANIZATION?